-
1
-
-
46749143660
-
Malignant melanoma in the 21st century: The emerging molecular landscape
-
DOI 10.4065/83.7.825
-
Sekulic A, Haluska P Jr., Miller AJ, Genebriera De Lamo J, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR and Markovic SN; Melanoma Study Group of Mayo Clinic Cancer Center: Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin Proc 83: 825-846, 2008. (Pubitemid 351948695)
-
(2008)
Mayo Clinic Proceedings
, vol.83
, Issue.7
, pp. 825-846
-
-
Sekulic, A.1
Haluska Jr., P.2
Miller, A.J.3
De Lamo, J.G.4
Ejadi, S.5
Pulido, J.S.6
Salomao, D.R.7
Thorland, E.C.8
Vile, R.G.9
Swanson, D.L.10
Pockaj, B.A.11
Laman, S.D.12
Pittelkow, M.R.13
Markovic, S.N.14
-
2
-
-
0029017087
-
Chromosome 9p deletions in cutaneous malignant melanoma tumors: The minimal deleted region involves markers outside of the p16 (CDKN2) gene
-
Puig S, Ruiz A, Lazaro C, Castel T, Lynch M, Palou J, Vilalta A, Weissenbach J, Mascaro JM and Estivill X: Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside of the p16 (CDKN2) gene. Am J Hum Genet 57: 395-402, 1995.
-
(1995)
Am J Hum Genet
, vol.57
, pp. 395-402
-
-
Puig, S.1
Ruiz, A.2
Lazaro, C.3
Castel, T.4
Lynch, M.5
Palou, J.6
Vilalta, A.7
Weissenbach, J.8
Mascaro, J.M.9
Estivill, X.10
-
3
-
-
0026483716
-
Homozygous deletions within human chromosome band 9p21 in melanoma
-
Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Vlock DR, Titus-Ernstoff L, Bouchard B, Vijayasaradhi S, Houghton AN, Lahti J, Kidd VJ, Housman DE and Dracopoli NC: Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 89: 10557-10561, 1992.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 10557-10561
-
-
Fountain, J.W.1
Karayiorgou, M.2
Ernstoff, M.S.3
Kirkwood, J.M.4
Vlock, D.R.5
Titus-Ernstoff, L.6
Bouchard, B.7
Vijayasaradhi, S.8
Houghton, A.N.9
Lahti, J.10
Kidd, V.J.11
Housman, D.E.12
Dracopoli, N.C.13
-
4
-
-
22844443766
-
Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines
-
DOI 10.1093/carcin/bgi066
-
Bloethner S, Chen B, Hemminki K, Müller-Berghaus J, Ugurel S, Schadendorf D and Kumar R: Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Carcinogenesis 26: 1224-1232, 2005. (Pubitemid 41417899)
-
(2005)
Carcinogenesis
, vol.26
, Issue.7
, pp. 1224-1232
-
-
Bloethner, S.1
Chen, B.2
Hemminki, K.3
Muller-Berghaus, J.4
Ugurel, S.5
Schadendorf, D.6
Kumar, R.7
-
5
-
-
0031777910
-
Retention of the CDKN2A locus and low frequency of point mutations in primary and metastasic cutaneous malignant melanoma
-
DOI 10.1002/(SICI)1097-0215(19980504)76:3<312::AID-IJC4>3.0.CO;2-Y
-
Ruiz A, Puig S, Lynch M, Castel T and Estivill X: Retention of the CDKN2A locus and low frequency of point mutations in primary and metastatic cutaneous malignant melanoma. Int J Cancer 76: 312-316, 1998. (Pubitemid 28282926)
-
(1998)
International Journal of Cancer
, vol.76
, Issue.3
, pp. 312-316
-
-
Ruiz, A.1
Puig, S.2
Lynch, M.3
Castel, T.4
Estivill, X.5
-
6
-
-
65349136425
-
Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell lines
-
Greshock J, Nathanson K, Medina A, Ward MR, Herlyn M, Weber BL and Zaks TZ: Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell lines. Genes Chromosomes Cancer 48: 419-428, 2009.
-
(2009)
Genes Chromosomes Cancer
, vol.48
, pp. 419-428
-
-
Greshock, J.1
Nathanson, K.2
Medina, A.3
Ward, M.R.4
Herlyn, M.5
Weber, B.L.6
Zaks, T.Z.7
-
7
-
-
2942533921
-
Microarray expression profiling in melanoma reveals a BRAF mutation signature
-
DOI 10.1038/sj.onc.1207563
-
Pavey S, Johansson P, Packer L, Taylor J, Stark M, Pollock PM, Walker GJ, Boyle GM, Harper U, Cozzi SJ, Hansen K, Yudt L, Schmidt C, Hersey P, Ellem KA, O'Rourke MG, Parsons PG, Meltzer P, Ringnér M and Hayward NK: Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene 23: 4060-4067, 2004. (Pubitemid 38747936)
-
(2004)
Oncogene
, vol.23
, Issue.23
, pp. 4060-4067
-
-
Pavey, S.1
Johansson, P.2
Packer, L.3
Taylor, J.4
Stark, M.5
Pollock, P.M.6
Walker, G.J.7
Boyle, G.M.8
Harper, U.9
Cozzi, S.-J.10
Hansen, K.11
Yudt, L.12
Schmidt, C.13
Hersey, P.14
Ellem, K.A.O.15
O'Rourke, M.G.E.16
Parsons, P.G.17
Meltzer, P.18
Ringner, M.19
Hayward, N.K.20
more..
-
8
-
-
34248630805
-
Confirmation of a BRAF mutation-associated gene expression signature in melanoma
-
DOI 10.1111/j.1600-0749.2007.00375.x
-
Johansson P, Pavey S, and Hayward N: Confirmation of a BRAF mutation-associated gene expression signature in melanoma. Pigment Cell Res 20: 216-221, 2007. (Pubitemid 46776377)
-
(2007)
Pigment Cell Research
, vol.20
, Issue.3
, pp. 216-221
-
-
Johansson, P.1
Pavey, S.2
Hayward, N.3
-
9
-
-
33745753404
-
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
-
DOI 10.1111/j.1600-0749.2006.00322.x
-
Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R, Weber BL, Nathanson KL, Phillips DJ, Herlyn M, Schadendorf D and Dummer R: Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 19: 290-302, 2006. (Pubitemid 44015592)
-
(2006)
Pigment Cell Research
, vol.19
, Issue.4
, pp. 290-302
-
-
Hoek, K.S.1
Schlegel, N.C.2
Brafford, P.3
Sucker, A.4
Ugurel, S.5
Kumar, R.6
Weber, B.L.7
Nathanson, K.L.8
Phillips, D.J.9
Herlyn, M.10
Schadendorf, D.11
Dummer, R.12
-
10
-
-
0042594373
-
Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine
-
DOI 10.1002/ijc.11242
-
Vilella R, Benitez D, Mila J, Vilalta A, Rull R, Cuellar F, Conill CVidal-Sicart S, Costa J, Yachi E, Palou J, Malvehy J, Puig S, Marti R, Mellado B and Castel T: Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine. Int J Cancer 106: 626-631, 2003. (Pubitemid 36966224)
-
(2003)
International Journal of Cancer
, vol.106
, Issue.4
, pp. 626-631
-
-
Vilella, R.1
Benitez, D.2
Mila, J.3
Vilalta, A.4
Rull, R.5
Cuellar, F.6
Conill, C.7
Vidal-Sicart, S.8
Costa, J.9
Yachi, E.10
Palou, J.11
Malvehy, J.12
Puig, S.13
Marti, R.14
Mellado, B.15
Castel, T.16
-
11
-
-
26444597589
-
Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees
-
DOI 10.1158/1055-9965.EPI-04-0777
-
Chaudru V, Laud K, Avril MF, Minière A, Chompret A, Bressacde Paillerets B and Demenais F: Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees. Cancer Epidemiol Biomarkers Prev 14: 2384-2390, 2005. (Pubitemid 41437841)
-
(2005)
Cancer Epidemiology Biomarkers and Prevention
, vol.14
, Issue.10
, pp. 2384-2390
-
-
Chaudru, V.1
Laud, K.2
Avril, M.-F.3
Miniere, A.4
Chompret, A.5
Bressac-De, P.B.6
Demenais, F.7
-
12
-
-
21144439424
-
Role of the CDKN2A locus in patients with multiple primary melanomas
-
DOI 10.1200/JCO.2005.08.034
-
Puig S, Malvehy J, Badenas C, Ruiz A, Jimenez D, Cuellar F, Azon A, Gonzàlez U, Castel T, Campoy A, Herrero J, Martí R, Brunet-Vidal J and Milà M: Role of the CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol 23: 3043-3051, 2005. (Pubitemid 46224126)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.13
, pp. 3043-3051
-
-
Puig, S.1
Malvehy, J.2
Badenas, C.3
Ruiz, A.4
Jimenez, D.5
Cuellar, F.6
Azon, A.7
Gonzalez, U.8
Castel, T.9
Campoy, A.10
Herrero, J.11
Marti, R.12
Brunet-Vidal, J.13
Mila, M.14
-
13
-
-
21044451716
-
Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: Therapeutic implications through protein modeling
-
DOI 10.1158/1078-0432.CCR-04-2515
-
Tarn C, Merkel E, Canutescu AA, Shen W, Skorobogatko Y, Heslin MJ, Eisenberg B, Birbe R, Patchefsky A, Dunbrack R, Arnoletti JP, von Mehren M and Godwin AK: Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Clin Cancer Res 11: 3668-3677, 2005. (Pubitemid 40685583)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.10
, pp. 3668-3677
-
-
Tarn, C.1
Merkel, E.2
Canutescu, A.A.3
Shen, W.4
Skorobogatko, Y.5
Heslin, M.J.6
Eisenberg, B.7
Birbe, R.8
Patchefsky, A.9
Dunbrack, R.10
Arnoletti, J.P.11
Von Mehren, M.12
Godwin, A.K.13
-
14
-
-
33749021085
-
Somatic activation of KIT in distinct subtypes of melanoma
-
DOI 10.1200/JCO.2006.06.2984
-
Curtin JA, Busam K, Pinkel D and Bastian C: Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24: 4340-4346, 2006. (Pubitemid 46630793)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.26
, pp. 4340-4346
-
-
Curtin, J.A.1
Busam, K.2
Pinkel, D.3
Bastian, B.C.4
-
15
-
-
0032920372
-
Mutational analysis within the 3' region of the PKD1 gene
-
DOI 10.1046/j.1523-1755.1999.00368.x
-
Badenas C, Torra R, San Millán JL, Lucero L, Milà M, Estivill X and Darnell A: Mutational analysis within the 3′ region of the PKD1 gene. Kidney Int 55: 1225-1233, 1999. (Pubitemid 29157118)
-
(1999)
Kidney International
, vol.55
, Issue.4
, pp. 1225-1233
-
-
Badenas, C.1
Torra, R.2
San, M.J.L.3
Lucero, L.4
Mila, M.5
Estivill, X.6
Darnell, A.7
-
16
-
-
33746589029
-
MC1R germline variants confer risk for BRAF-mutant melanoma
-
DOI 10.1126/science.1127515
-
Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kanetsky PA, Pinkel D and Bastian BC: MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313: 521-522, 2006. (Pubitemid 44148456)
-
(2006)
Science
, vol.313
, Issue.5786
, pp. 521-522
-
-
Landi, M.T.1
Bauer, J.2
Pfeiffer, R.M.3
Elder, D.E.4
Hulley, B.5
Minghetti, P.6
Calista, D.7
Kanetsky, P.A.8
Pinkel, D.9
Bastian, B.C.10
-
17
-
-
2342634253
-
Biological significance of the defense mechanisms against oxidative damage in nucleic acids caused by reactive oxygen species: From mitochondria to nuclei
-
DOI 10.1196/annals.1293.011
-
Nakabeppu Y, Tsuchimoto D, Ichinoe A, Ohno M, Ide Y, Hirano S, Yoshimura D, Tominaga Y, Furuichi M, and Sakumi K: Biological significance of the defense mechanisms against oxidative damage in nucleic acids caused by reactive oxygen species: from mitochondria to nuclei. Ann NY Acad Sci 1011: 101-111, 2004. (Pubitemid 38608396)
-
(2004)
Annals of the New York Academy of Sciences
, vol.1011
, pp. 101-111
-
-
Nakabeppu, Y.1
Tsuchimoto, D.2
Ichinoe, A.3
Ohno, M.4
Ide, Y.5
Hirano, S.6
Yoshimura, D.7
Tominaga, Y.8
Furuichi, M.9
Sakumi, K.10
-
18
-
-
0036478899
-
Inherited variants of MYH associated with somatic G:C-T:A mutations in colorectal tumors
-
Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS, Sampson JR and Cheadle JP: Inherited variants of MYH associated with somatic G:C-T:A mutations in colorectal tumors. Nat Genet 30: 227-232, 2002.
-
(2002)
Nat Genet
, vol.30
, pp. 227-232
-
-
Al-Tassan, N.1
Chmiel, N.H.2
Maynard, J.3
Fleming, N.4
Livingston, A.L.5
Williams, G.T.6
Hodges, A.K.7
Davies, D.R.8
David, S.S.9
Sampson, J.R.10
Cheadle, J.P.11
-
19
-
-
33745903402
-
MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype
-
DOI 10.1002/ijc.21905
-
Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C, Mangold E, Caspari R, Propping P and Friedl W: MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 119: 807-814, 2006. (Pubitemid 44051443)
-
(2006)
International Journal of Cancer
, vol.119
, Issue.4
, pp. 807-814
-
-
Aretz, S.1
Uhlhaas, S.2
Goergens, H.3
Siberg, K.4
Vogel, M.5
Pagenstecher, C.6
Mangold, E.7
Caspari, R.8
Propping, P.9
Friedl, W.10
-
20
-
-
0029883639
-
Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi
-
Goldstein AM, Goldin LR, Dracopoli NC, Clark WH Jr. and Tucker MA: Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi. Am J Hum Genet 58: 1050-1056, 1996. (Pubitemid 26115177)
-
(1996)
American Journal of Human Genetics
, vol.58
, Issue.5
, pp. 1050-1056
-
-
Goldstein, A.M.1
Goldin, L.R.2
Dracopoli, N.C.3
Clark Jr., W.H.4
Tucker, M.A.5
-
21
-
-
0041664874
-
Localization of a novel melanoma susceptibility locus to 1p22
-
DOI 10.1086/377140
-
Gillanders E, Juo SH, Holland EA, Jones M, Nancarrow D, Freas-Lutz D, Sood R, Park N, Faruque M, Markey C, Kefford RF, Palmer J, Bergman W, Bishop DT, Tucker MA, Bressac-de Paillerets B, Hansson J, Stark M, Gruis N, Bishop JN, Goldstein AM, Bailey-Wilson JE, Mann GJ, Hayward N and Trent J; Lund Melanoma Study Group; Melanoma Genetics Consortium: Localization of a novel melanoma susceptibility locus to 1p22. Am J Hum Genet 73: 301-313, 2003. (Pubitemid 36920993)
-
(2003)
American Journal of Human Genetics
, vol.73
, Issue.2
, pp. 301-313
-
-
Gillanders, E.1
Juo, S.-H.H.2
Holland, E.A.3
Jones, M.4
Nancarrow, D.5
Freas-Lutz, D.6
Sood, R.7
Park, N.8
Faruque, M.9
Markey, C.10
Kefford, R.F.11
Palmer, J.12
Bergman, W.13
Bishop, D.T.14
Tucker, M.A.15
Bressac-De, P.B.16
Hansson, J.17
Stark, M.18
Gruis, N.19
Bishop, J.N.20
Goldstein, A.M.21
Bailey-Wilson, J.E.22
Mann, G.J.23
Hayward, N.24
Trent, J.25
more..
-
22
-
-
0038797067
-
Identification of novel deletion loci at 1p36 and 9p22-21 in melanocytic dysplastic nevi and cutaneous malignant melanomas
-
DOI 10.1001/archderm.139.6.816
-
Hussein MR, Roggero E, Tuthill RJ, Wood GS and Sudilovsky O: Identification of novel deletion loci at 1p36 and 9p22-21 in melanocytic dysplastic nevi and cutaneous malignant melanoma. Arch Dermatol 139: 816-817, 2003. (Pubitemid 36705961)
-
(2003)
Archives of Dermatology
, vol.139
, Issue.6
, pp. 816-817
-
-
Hussein, M.R.1
Roggero, E.2
Tuthill, R.J.3
Wood, G.S.4
Sudilovsky, O.5
-
23
-
-
0037331353
-
Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: Fine mapping in search of a possible tumour suppressor gene region
-
DOI 10.1097/00008390-200302000-00006
-
Poetsch M, Dittberner T and Woenckhaus C: Microsatellite analysis at 1p36.3 in malignant melanoma of the skin: fine mapping in search of a possible tumor suppressor gene region. Melanoma Res 13: 29-33, 2003. (Pubitemid 36269811)
-
(2003)
Melanoma Research
, vol.13
, Issue.1
, pp. 29-33
-
-
Poetsch, M.1
Dittberner, T.2
Woenckhaus, C.3
-
24
-
-
0037163082
-
1 phase progression
-
DOI 10.1074/jbc.M202528200
-
Obaya AJ, Kotenko I, Cole MD and Sedivy JM: The protooncogene c-Myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression. J Biol Chem 277: 31263-31269, 2002. (Pubitemid 34970835)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.34
, pp. 31263-31269
-
-
Obaya, A.J.1
Kotenko, I.2
Cole, M.D.3
Sedivy, J.M.4
-
25
-
-
49649092403
-
Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: A Southwest Oncology Group study (S9431)
-
Moore SR, Persons DL, Sosman JA, Bobadilla D, Bedell V, Smith DD, Wolman SR, Tuthill RJ, Moon J, Sondak VK and Slovak ML: Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a Southwest Oncology Group study (S9431). Clin Cancer Res 14: 2927-2935, 2008.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2927-2935
-
-
Moore, S.R.1
Persons, D.L.2
Sosman, J.A.3
Bobadilla, D.4
Bedell, V.5
Smith, D.D.6
Wolman, S.R.7
Tuthill, R.J.8
Moon, J.9
Sondak, V.K.10
Slovak, M.L.11
-
26
-
-
56149126490
-
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells
-
Zhuang D, Mannava S, Grachtchouk V, Tang WH, Patil S, Wawrzyniak JA, Berman AE, Giordano TJ, Prochownik EV, Soengas MS and Nikiforov MA: c-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 27: 6623-6634, 2008.
-
(2008)
Oncogene
, vol.27
, pp. 6623-6634
-
-
Zhuang, D.1
Mannava, S.2
Grachtchouk, V.3
Tang, W.H.4
Patil, S.5
Wawrzyniak, J.A.6
Berman, A.E.7
Giordano, T.J.8
Prochownik, E.V.9
Soengas, M.S.10
Nikiforov, M.A.11
-
27
-
-
34047258036
-
Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays
-
DOI 10.1158/0008-5472.CAN-06-4152
-
Stark M and Hayward N: Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 67: 2632-2642, 2007. (Pubitemid 46548950)
-
(2007)
Cancer Research
, vol.67
, Issue.6
, pp. 2632-2642
-
-
Stark, M.1
Hayward, N.2
-
28
-
-
17144399192
-
Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival
-
DOI 10.1158/1078-0432.CCR-04-1731
-
Grafström E, Egyházi S, Ringborg U, Hansson J and Platz A: Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival. Clin Cancer Res 11: 2991-2997, 2005. (Pubitemid 40525204)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.8
, pp. 2991-2997
-
-
Grafstrom, E.1
Egyhezi, S.2
Ringborg, U.3
Hansson, J.4
Platz, A.5
-
29
-
-
0042846001
-
Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma
-
Behrmann I, Wallner S, Komyod W, Heinrich PC, Schuierer M, Buettner R and Bosserhoff AK: Characterization of methylthioadenosine Phosphorylase (MTAP) expression in malignant melanoma. Am J Pathol 163: 683-690, 2003. (Pubitemid 36909429)
-
(2003)
American Journal of Pathology
, vol.163
, Issue.2
, pp. 683-690
-
-
Behrmann, I.1
Wallner, S.2
Komyod, W.3
Heinrich, P.C.4
Schuierer, M.5
Buettner, R.6
Bosserhoff, A.-K.7
-
30
-
-
0029980941
-
Temperature-sensitive mutants of p16/CDKN2 associated with familial melanoma
-
Parry D and Peters G: Temperature-sensitive mutants of p16/CDKN2 associated with familial melanoma. Mol Cell Biol 16: 3844-3852, 1996.
-
(1996)
Mol Cell Biol
, vol.16
, pp. 3844-3852
-
-
Parry, D.1
Peters, G.2
-
31
-
-
0029147195
-
Evidence for U.V. induction of CDKN2 mutations in melanoma cell lines
-
Pollock PM, Yu F, Qiu L, Parsons PG and Hayward NK: Evidence for U.V. induction of CDKN2 mutations in melanoma cell lines. Oncogene 11: 663-668, 1995.
-
(1995)
Oncogene
, vol.11
, pp. 663-668
-
-
Pollock, P.M.1
Yu, F.2
Qiu, L.3
Parsons, P.G.4
Hayward, N.K.5
|